BMGL (Basel Medical Group Ltd Ordinary Shares) Stock Analysis - SEC Filings

Basel Medical Group Ltd Ordinary Shares (BMGL) is a publicly traded Healthcare sector company. As of May 21, 2026, BMGL trades at $0.63 with a market cap of $12.39M and a P/E ratio of 0.00. BMGL moved +0.00% today. Year to date, BMGL is +9.49%; over the trailing twelve months it is -67.59%. Its 52-week range spans $0.49 to $9.40. Rallies surfaces BMGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find BMGL SEC filings?

Rallies organizes BMGL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

BMGL Key Metrics

Key financial metrics for BMGL
MetricValue
Price$0.63
Market Cap$12.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$9.40
52-Week Low$0.49
Volume2
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BMGL News

BMGL Analyst Consensus

BMGL analyst coverage data. Average price target: $0.00.

Common questions about BMGL

Where can I find BMGL SEC filings?
Rallies organizes BMGL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show BMGL 10-K and 10-Q filings?
Rallies organizes BMGL SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is BMGL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BMGL. It does not provide personalized investment advice.
BMGL

BMGL